lanadelumab   Click here for help

GtoPdb Ligand ID: 9094

Synonyms: DX-2930 | lanadelumab-flyo | Takhzyro® | X124-G01
Approved drug
lanadelumab is an approved drug (EMA & FDA (2018))
Compound class: Antibody
Comment: Lanadelumab is a fully human monoclonal antibody targeting the serine peptidase kallikrein B1 (KLKB1, a.k.a. plasma kallikrein). It is generated in recombinant Chinese hamster ovary cells.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent US8816055 [5].
Click here for help
Classification Click here for help
Compound class Antibody
Approved drug? Yes (EMA & FDA (2018))
International Nonproprietary Names Click here for help
INN number INN
10265 lanadelumab
Synonyms Click here for help
DX-2930 | lanadelumab-flyo | Takhzyro® | X124-G01
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 607
Other databases
GtoPdb PubChem SID 315661179
Search PubMed clinical trials lanadelumab
Search PubMed titles lanadelumab
Search PubMed titles/abstracts lanadelumab